Complementary strategies to target residual immune activation and mucosal dysfunction in treated HIV: role of probiotics and pidotimod

Katia Falasca, Raffaele Ferri, Jacopo Vecchiet

Open source

DOI
10.3389/fcimb.2026.1985254
Published
2026-10-21
Container
Frontiers in Cellular and Infection Microbiology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2026.1985254,
  title = {Complementary strategies to target residual immune activation and mucosal dysfunction in treated HIV: role of probiotics and pidotimod},
  author = {Katia Falasca and Raffaele Ferri and Jacopo Vecchiet},
  year = {2026},
  journal = {Frontiers in Cellular and Infection Microbiology},
  doi = {10.3389/fcimb.2026.1985254},
  url = {https://doi.org/10.3389/fcimb.2026.1985254}
}

RIS

TY  - JOUR
TI  - Complementary strategies to target residual immune activation and mucosal dysfunction in treated HIV: role of probiotics and pidotimod
AU  - Katia Falasca
AU  - Raffaele Ferri
AU  - Jacopo Vecchiet
PY  - 2026
JO  - Frontiers in Cellular and Infection Microbiology
DO  - 10.3389/fcimb.2026.1985254
UR  - https://doi.org/10.3389/fcimb.2026.1985254
ER  - 

APA

Falasca, K., Ferri, R., & Vecchiet, J. (2026). Complementary strategies to target residual immune activation and mucosal dysfunction in treated HIV: role of probiotics and pidotimod. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1985254

Source records